TCR2 THERAPEUTICS INC. Chart calendar TCR2 Therapeutics Inc.
646176c95a7e5.rOmWy-qgffRGhYAuZsazc3m5pItBy7lU9cDkvg1ZA00.2pPjk4HTBcQW6sVeH47_OQ7Rkbl5o4gAw7KX6jpvMCydn9GPx9UUpyjNxQ~7429c5c5b5b195fd259b937590cbfd22
Past events on TCR2 Therapeutics Inc.
| 31/03/2024 | Q4 2023 Earnings Release (Projected) |
| 30/05/2023 13:00 | Extraordinary Shareholders Meeting - M&A Vote |
| 11/05/2023 11:30 | Q1 2023 Earnings Release |
| 23/03/2023 10:30 | Q4 2022 Earnings Release |
| 14/02/2023 18:00 | SVB Securities Global Biopharma Conference |
| 29/11/2022 19:00 | Piper Sandler Healthcare Conference |
| 15/11/2022 17:35 | Jefferies London Healthcare Conference |
| 08/11/2022 11:45 | Q3 2022 Earnings Release |
| 07/11/2022 16:40 | Society for Immunotherapy of Cancer Conference - Abstract Number: 219 |
| 13/10/2022 | Annual General Meeting |
| 29/09/2022 19:00 | Jefferies Cell and Genetic Medicine Summit |
| 28/09/2022 13:00 | Gavo-cel Phase 1 Trial Results Call |
| 09/08/2022 | Wedbush PacGrow Healthcare Conference |
| 08/08/2022 11:45 | Interim 2022 Earnings Release |
| 27/06/2022 17:00 | Truist Securities Life Sciences Symposia-cel Conference |
| 08/06/2022 19:00 | Jefferies Healthcare Conference |
| 24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 12/05/2022 11:45 | Q1 2022 Earnings Release |
| 10/04/2022 19:30 | American Association of Cancer Research Meeting - Poster: 4716 |
| 22/03/2022 10:45 | FY 2021 Earnings Release |
More events
